Phase II study of erlotinib in elderly patients with non-small cell lung cancer harboring epidermal growth factor receptor mutations
2015 ◽
Vol 76
(1)
◽
pp. 155-161
◽
2007 ◽
Vol 2
(8)
◽
pp. S733-S734
2014 ◽
Vol 32
(15_suppl)
◽
pp. e19095-e19095
2002 ◽
Vol 38
◽
pp. S153
◽
2011 ◽
Vol 41
(8)
◽
pp. 959-963
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. 7559-7559